Mechanical Aspiration in ST Elevation ACS

In ST elevation ACS the preferred treatment is primary PCI. However, one its limitations is thrombus presence and its distal embolization, which threatens microcirculation perfusion and is therefore associated to ventricular function deterioration and bad evolution.

Aspiración mecánica en el IAM con supradesnivel del ST

Manual thrombus aspiration has been tested in different studies but the problem remains unsolved; mechanical thrombectomy might be a solution to this complication, so difficult to handle. 

The CHEETAH study (prospective, multicenter) included 400 patients with ST-ACS presenting within 12 hrs. of symptom onset treated with mechanical thrombectomy with CAT RX Aspiration System (Penumbra Inc, Alameda CA). 

Primary end point was a composite of cardiovascular death, repeat MI, cardiogenic shock or new class IV cardiac failure at 30 days.

Mean age was 60, most patients were men, 25% were diabetic, 2% had prior CABG and 20% prior PCI.

Most patients were in Killip class I-II. Compromised arteries were the right coronary, in half of patients, followed by the anterior descending and, less frequently, the circumflex. 

Read also: ACC 2023 | Subanalysis of the REVIVED-BICS Study2.

 Final rates of TIMI 0 was 99.50%, TIMI flow 3, 97.50% and myocardial blush grade 3 was 99.75%, with no device complications. 

Primary end point occurred in 3.6% of cases (95% CI, 2.0–6.0%) compared against the historical rate of 6.1%  (Pnoninferiority <0.001).

At 30 days, cardiovascular mortality was 0.51%, stroke 0.77%, major bleeding 1%.

Conclusion

Mechanical aspiration before PCI in acute coronary syndrome with high thrombus burden was safe, and was associated to high thrombus removal with flow restauration and normal perfusion on final angiography. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board ofSOLACI.org.

Original Title: Sustained Mechanical Aspiration Thrombectomy for High Thrombus Burden Coronary Vessel Occlusion: The Multicenter CHEETAH Study.

Reference: S. Jay Mathews, et al. Circ Cardiovasc Interv. 2023;16:e012433. DOI: 10.1161/CIRCINTERVENTIONS.122.012433. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....